Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Willebrand factor type A and cache domain-containing protein 1 (CACHD1) is a single-pass transmembrane glycoprotein identified as an α2δ-like auxiliary subunit that regulates the function and cell surface expression of certain voltage-gated calcium channels, including T-type (Cav3.x) and N-type (Cav2.2) channels[1][3][4][5]. It contains two extracellular cache domains—structural motifs usually found in bacterial chemosensors—and a von Willebrand factor type A (VWFA) domain featuring a variant MIDAS motif, features it shares with canonical α2δ channel subunits[2][3]. CACHD1 is involved in neuronal signaling and calcium ion homeostasis in the central and peripheral nervous systems, with strong implications in auditory and vestibular biology as shown by hearing loss and balance defects in knockout mouse models[4]. While its direct association with specific human diseases is still being studied, its modulation of calcium channel function suggests potential involvement in sensory disorders, pain, epilepsy, and perhaps metabolic traits[1][3][4]. CACHD1 remains a candidate for future therapeutic targeting, notably as an alternative to more directly modulating channel pore-forming subunits or for fine-tuned control of neuronal excitability[3][4].
Modulation of voltage-gated calcium channel open probability and surface expression; increases T-type (Cav3.x) and N-type (Cav2.2) calcium currents, competes with canonical α2δ subunits for channel modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand factor type A and cache domain-containing protein 1 (CACHD1).